Pharmaceutical care needs in prevention of coronary heart disease in type 2 diabetes mellitus
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: ACIU, Mariana (University of Medicine and Pharmacy, Faculty of Pharmacy, Craiova, Romania)
- Co-author(s): Calina, Daniela (University of Medicine and Pharmacy, CRAIOVA, Romania)
AIMS: The objective of this descriptive and retrospective study is to assess the pharmaceutical needs of type 2 diabetes in relation to primary prevention of coronary heart disease (CHD), because type 2 diabetes is a strong risk factor for CHD and is associared with a 2-4 fold increased risk for coronary heart compared with non-diadetics.
.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.